Clinical observation of a patient with multiple endocrine neoplasia syndrome type 2a
https://doi.org/10.21886/2712-8156-2024-5-3-96-101
Abstract
The article is devoted to the clinical observation of a patient with multiple endocrine neoplasia syndrome 2A, characterized by a combination of pheochromocytoma, medullary thyroid cancer and hyperplasia of the parathyroid glands. The features of diagnostics of this disease, preoperative preparation, as well as principles of observation for several years after surgical treatment are described. In addition, data on the features of diagnostic search and tactics of management of family members with this syndrome are provided.
About the Authors
N. A. Kuzmenko
Rostov State Medical University
Russian Federation
Russian Federation
Nataliya A. Kuzmenko, Cand. Sci. (Med.), Associate Professor, Department of Endocrinology (with a course in pediatric endocrinology)
Rostov-on-Don
I. A. Khripun
Rostov State Medical University
Russian Federation
Russian Federation
Irina A. Khripun, Dr. Sci. (Med.), Professor at the Department of Endocrinology (with a course in pediatric endocrinology)
Rostov-on-Don
S. V. Vorobyev
Rostov State Medical University
Russian Federation
Russian Federation
Sergey V. Vorobyev, Dr. Sci. (Med.), Professor at the Department of Endocrinology (with a course in pediatric endocrinology)
Rostov-on-Don
E. E. Gemidzhe
Rostov State Medical University
Russian Federation
Russian Federation
Evelina E. Gemidzhe, Endocrinologist at the Department of Endocrinology (with a course in pediatric endocrinology)
Rostov-on-Don
K. M. Kolikova
Rostov State Medical University
Russian Federation
Russian Federation
Karina M. Kolikova, Endocrinologist
Rostov-on-Don
References
1. Znaczko A, Donnelly DE, Morrison PJ. Epidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete population. Oncologist. 2014;19(12):1284- 1286. DOI: 10.1634/theoncologist.2014-0277
2. Iukina M.I., Goncharov N.P., Bel’tsevich D.G., Troshina E.A. Multiple type 2 endocrine neoplasia (case report). Problems of Endocrinology. 2011;57(6):21-26. (In Russ.) DOI: 10.14341/probl201157621-26
3. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86(12):5658- 5671. DOI: 10.1210/jcem.86.12.8070
4. Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567-610. DOI: 10.1089/thy.2014.0335
5. Li AY, McCusker MG, Russo A, Scilla KA, Gittens A, Arensmeyer K, et al. RET fusions in solid tumors. Cancer Treat Rev. 2019;81:101911. DOI: 10.1016/j.ctrv.2019.101911
6. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 1993;2(7):851- 856. DOI: 10.1093/hmg/2.7.851
7. Imai T, Uchino S, Okamoto T, Suzuki S, Kosugi S, Kikumori T, et al. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients. Eur J Endocrinol. 2013;168(5):683-687. DOI: 10.1530/EJE-12-1106
8. Mathiesen JS, Effraimidis G, Rossing M, Rasmussen ÅK, Hoejberg L, Bastholt L, et al. Multiple endocrine neoplasia type 2: A review. Semin Cancer Biol. 2022;79:163-179. DOI: 10.1016/j.semcancer.2021.03.035
9. Severskaya N.V., Il’in A.A., Isaev P.A., Shinkarkina A.P., Chebotareva I.V., Derbugov D.N., i dr. Sindrom MEN 2a: fokus na mutatsiyu v 634 kodone. Innovatsionnye tekhnologii v endokrinologii: sbornik tezisov III Vserossiiskogo endokrinologicheskogo kongressa s mezhdunarodnym uchastiem. Moskva; 2017. (In Russ.) eLIBRARY ID: 32532223 EDN: YQSNIC
10. The diagnosis and treatment of medullary thyroid cancer. National clinical guidelines. Tumors of the head and neck. 2013;(4):36-45. (In Russ.). eLIBRARY ID: 21592535 EDN: SENGFD
11. Szinnai G, Meier C, Komminoth P, Zumsteg UW. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis. Pediatrics. 2003;111(2):E132-9. DOI: 10.1542/peds.111.2.e132
12. Dedov I.I., Mel’nichenko G.A., eds. Jendokrinologija. Nacional’noe rukovodstvo. GEOTAR-Media; 2013. (in Russ.).
13. American Thyroid Association Guidelines Task Force; Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19(6):565-612. Erratum in: Thyroid. 2009;19(11):1295. DOI: 10.1089/thy.2008.0403
14. Demidova T.Yu., Kishkowich Yu.S. Multiple endocrine neoplasia syndrome type 2. RMJ. 2018;11(II):116-121. (In Russ.)
15. Machens A, Dralle H. Multiple endocrine neoplasia type 2: towards a risk-based approach integrating molecular and biomarker results. Curr Opin Oncol. 2024;36(1):1-12. DOI: 10.1097/CCO.0000000000001009
Review
For citations:
Kuzmenko N.A., Khripun I.A., Vorobyev S.V., Gemidzhe E.E., Kolikova K.M. Clinical observation of a patient with multiple endocrine neoplasia syndrome type 2a. South Russian Journal of Therapeutic Practice. 2024;5(3):96-101. (In Russ.) https://doi.org/10.21886/2712-8156-2024-5-3-96-101
Views:
223
Email this article 